Market Cap 2.01B
Revenue (ttm) 74.68M
Net Income (ttm) -644.76M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -863.36%
Debt to Equity Ratio 0.01
Volume 32,680,398
Avg Vol 18,762,932
Day's Range N/A - N/A
Shares Out 529.91M
Stochastic %K 75%
Beta 1.00
Analysts Sell
Price Target $6.31

Company Profile

Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States and the United Kingdom. The company develops REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-617, which is in Phase 1/2 clinical trial to treat advanced solid tumors; REC-12...

Industry: Biotechnology
Sector: Healthcare
Phone: 385 269 0203
Address:
41 South Rio Grande Street, Salt Lake City, United States
Floridaorange
Floridaorange Jul. 4 at 4:39 AM
$RXRX is the only publicly traded company that has assembled the combination of proprietary data generation, automated labs, AI research (Valence Labs), supercomputing (BioHive), foundation models, and an integrated discovery platform all under one roof. Buy, hold, wait, win.
0 · Reply
stockit111
stockit111 Jul. 4 at 1:27 AM
$RXRX What's next move, down to $3 again or hold $4 this time? Place your bets.
1 · Reply
AlgorithmApex
AlgorithmApex Jul. 3 at 9:38 PM
$RXRX starting to look like a real trend, not just a dead-cat bounce. Price action is holding up instead of fading, and that’s the key shift. If buyers keep defending dips, this can keep grinding higher.
0 · Reply
topstockalerts
topstockalerts Jul. 3 at 8:51 PM
$RXRX this is starting to look like a trend, not just a bounce
0 · Reply
NatesNotes
NatesNotes Jul. 3 at 5:15 PM
Now that my subscribers have had plenty of time to act on the information in both, I thought I'd share the last two issues of the newsletter on the free side of the website for those of you who may be interested! The link below will take you to the June issue (and the May issue will be just a click away once you get there), which includes some commentary on $SPCX and the frothiness of the market these days, and both issues include a fair amount of commentary discussing my thoughts on $MNKD as the story has been unfolding over the past couple of months (which, of course, is why I am sharing the link on the MNKD stream... though $AAPL, $NVDA, $RXRX and all the other recommended stocks are discussed as well). Anyhow, take a gander if you'd like... and please don't hesitate to ask if you have any questions after reading them! As always, kudos to everyone who has managed to keep their wits about them along the way - here's to more gains in the years ahead! Cheers! https://www.notwallstreet.com/the-frothiness-continues-to-grow-plus-spacex-mannkind-and-more-7-3-26/
4 · Reply
Sihtegroftnod
Sihtegroftnod Jul. 3 at 4:42 AM
$RXRX excited for 2026!!!
0 · Reply
ThisStockisDogShit
ThisStockisDogShit Jul. 3 at 2:13 AM
$FABC $JACK $RXRX $WEN Jack in the box fucking hates children clearly. Stay off our boards lil btch
2 · Reply
Reddskin
Reddskin Jul. 3 at 2:08 AM
1 · Reply
MorganHoratio
MorganHoratio Jul. 2 at 11:29 PM
One of the strongest sectors outside of AI right now is Biotech. Drug Discovery $TWST Twist Bioscience $ABSI Absci $RXRX Recursion $ABCL AbCellera $NRIX Nurix Therapeutics Smart money is pivoting to the ultimate AI crossover: Drug Discovery & TechBio! This sector captures AI’s efficiency boom without the tech sector’s valuation bubble. DNA giant TWST is absolutely ripping, up over 200% this year to fresh historical highs on strong revenue growth. Protein degradation leader NRIX also just smashed 52-week highs. Alongside Nvidia-backed RXRX, ABSI, and ABCL, this sector is using AI algorithms to shatter traditional pharma limits. Can AI Biotech outpace pure tech in H2? Which ticker is your top play: TWST, ABSI, RXRX, ABCL, or NRIX? Drop your picks below! 👇
0 · Reply
Esusthu
Esusthu Jul. 2 at 8:57 PM
$RXRX Very interesting biotech with major pharmaceutical partnerships and multiple near-term clinical catalysts that could drive significant long-term growth. I do believe!
0 · Reply
Latest News on RXRX
Recursion Pharmaceuticals Transcript: AGM 2026

Jun 17, 2026, 2:00 PM EDT - 17 days ago

Recursion Pharmaceuticals Transcript: AGM 2026


Recursion to Participate in Upcoming Investor Conferences

Jun 2, 2026, 8:00 AM EDT - 4 weeks ago

Recursion to Participate in Upcoming Investor Conferences


Recursion Pharmaceuticals reports Q1 EPS (22c), consensus (26c)

2026-05-07T09:29:09.000Z - 2 months ago

Recursion Pharmaceuticals reports Q1 EPS (22c), consensus (26c)


Recursion Pharmaceuticals Earnings Call Transcript: Q1 2026

May 6, 2026, 8:00 AM EDT - 2 months ago

Recursion Pharmaceuticals Earnings Call Transcript: Q1 2026


Recursion Pharmaceuticals Earnings release: Q1 2026

May 6, 2026, 8:00 AM EDT - 2 months ago

Recursion Pharmaceuticals Earnings release: Q1 2026


Recursion Pharmaceuticals Quarterly report: Q1 2026

May 6, 2026, 8:00 AM EDT - 2 months ago

Recursion Pharmaceuticals Quarterly report: Q1 2026


Recursion Pharmaceuticals Slides: Q1 2026

May 6, 2026, 8:00 AM EDT - 2 months ago

Recursion Pharmaceuticals Slides: Q1 2026


Recursion Announces Board Transition

Apr 30, 2026, 4:30 PM EDT - 2 months ago

Recursion Announces Board Transition


Recursion Pharmaceuticals Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

Recursion Pharmaceuticals Proxy statement: Proxy filing


Recursion Pharmaceuticals Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

Recursion Pharmaceuticals Proxy statement: Proxy filing


PacBio appoints Gibson to Board of Directors

2026-03-05T13:44:59.000Z - 4 months ago

PacBio appoints Gibson to Board of Directors

PACB


Recursion Pharmaceuticals Earnings Call Transcript: Q4 2025

Feb 25, 2026, 8:00 AM EST - 4 months ago

Recursion Pharmaceuticals Earnings Call Transcript: Q4 2025


Recursion Pharmaceuticals Annual report: Q4 2025

Feb 25, 2026, 8:00 AM EST - 4 months ago

Recursion Pharmaceuticals Annual report: Q4 2025


Recursion Pharmaceuticals Earnings release: Q4 2025

Feb 25, 2026, 8:00 AM EST - 4 months ago

Recursion Pharmaceuticals Earnings release: Q4 2025


Recursion Pharmaceuticals Slides: Q4 2025

Feb 25, 2026, 8:00 AM EST - 4 months ago

Recursion Pharmaceuticals Slides: Q4 2025


Recursion Pharmaceuticals reports Q4 EPS (21c), consensus (32c)

2026-02-25T11:47:23.000Z - 4 months ago

Recursion Pharmaceuticals reports Q4 EPS (21c), consensus (32c)


What's Happening With RXRX Stock?

Dec 18, 2025, 11:05 AM EST - 7 months ago

What's Happening With RXRX Stock?


Recursion Pharmaceuticals Transcript: Study Update

Dec 8, 2025, 8:00 AM EST - 7 months ago

Recursion Pharmaceuticals Transcript: Study Update


Recursion Pharmaceuticals Press release: Study Update

Dec 8, 2025, 8:00 AM EST - 7 months ago

Recursion Pharmaceuticals Press release: Study Update


Recursion Pharmaceuticals Slides: Study Update

Dec 8, 2025, 8:00 AM EST - 7 months ago

Recursion Pharmaceuticals Slides: Study Update


Recursion Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 5, 2025, 8:00 AM EST - 8 months ago

Recursion Pharmaceuticals Earnings Call Transcript: Q3 2025


Recursion Pharmaceuticals Quarterly report: Q3 2025

Nov 5, 2025, 8:00 AM EST - 8 months ago

Recursion Pharmaceuticals Quarterly report: Q3 2025


Recursion Pharmaceuticals Earnings release: Q3 2025

Nov 5, 2025, 8:00 AM EST - 8 months ago

Recursion Pharmaceuticals Earnings release: Q3 2025


Recursion Pharmaceuticals Slides: Q3 2025

Nov 5, 2025, 8:00 AM EST - 8 months ago

Recursion Pharmaceuticals Slides: Q3 2025


Recursion Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 11 months ago

Recursion Pharmaceuticals Earnings Call Transcript: Q2 2025


Recursion Pharmaceuticals Quarterly report: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 11 months ago

Recursion Pharmaceuticals Quarterly report: Q2 2025


Recursion Pharmaceuticals Earnings release: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 11 months ago

Recursion Pharmaceuticals Earnings release: Q2 2025


Recursion Pharmaceuticals Slides: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 11 months ago

Recursion Pharmaceuticals Slides: Q2 2025


Recursion Pharmaceuticals Earnings Call Transcript: Q1 2025

May 5, 2025, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Earnings Call Transcript: Q1 2025


Recursion Pharmaceuticals Quarterly report: Q1 2025

May 5, 2025, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Quarterly report: Q1 2025


Recursion Pharmaceuticals Earnings release: Q1 2025

May 5, 2025, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Earnings release: Q1 2025


Recursion Pharmaceuticals Slides: Q1 2025

May 5, 2025, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Slides: Q1 2025


Recursion Pharmaceuticals Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Proxy statement: Proxy Filing


Recursion Pharmaceuticals Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Proxy statement: Proxy Filing


Recursion to Participate in Upcoming Investor Conference

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Recursion to Participate in Upcoming Investor Conference


Recursion Pharmaceuticals Earnings Call Transcript: Q4 2024

Feb 28, 2025, 8:30 AM EST - 1 year ago

Recursion Pharmaceuticals Earnings Call Transcript: Q4 2024


Recursion Pharmaceuticals Annual report: Q4 2024

Feb 28, 2025, 8:30 AM EST - 1 year ago

Recursion Pharmaceuticals Annual report: Q4 2024


Recursion Pharmaceuticals Earnings release: Q4 2024

Feb 28, 2025, 8:30 AM EST - 1 year ago

Recursion Pharmaceuticals Earnings release: Q4 2024


Recursion Pharmaceuticals Slides: Q4 2024

Feb 28, 2025, 8:30 AM EST - 1 year ago

Recursion Pharmaceuticals Slides: Q4 2024


Altitude Lab Startups Raise $154M in Capital

Feb 18, 2025, 11:00 AM EST - 1 year ago

Altitude Lab Startups Raise $154M in Capital


Recursion Pharmaceuticals Slides: FY 2025

Jan 13, 2025, 10:30 AM EST - 1 year ago

Recursion Pharmaceuticals Slides: FY 2025


Recursion Pharmaceuticals Transcript: Status Update

Dec 9, 2024, 7:00 PM EST - 1 year ago

Recursion Pharmaceuticals Transcript: Status Update


Recursion Pharmaceuticals Slides: Status Update

Dec 9, 2024, 7:00 PM EST - 1 year ago

Recursion Pharmaceuticals Slides: Status Update


Recursion Pharmaceuticals Transcript: Status Update

Nov 20, 2024, 7:30 AM EST - 1 year ago

Recursion Pharmaceuticals Transcript: Status Update


Recursion Pharmaceuticals Press release: Status Update

Nov 20, 2024, 7:30 AM EST - 1 year ago

Recursion Pharmaceuticals Press release: Status Update


Recursion Pharmaceuticals Proxy statement: Proxy Filing

Nov 6, 2024, 7:00 AM EST - 1 year ago

Recursion Pharmaceuticals Proxy statement: Proxy Filing


Recursion Pharmaceuticals Quarterly report: Q3 2024

Nov 6, 2024, 2:30 AM EST - 1 year ago

Recursion Pharmaceuticals Quarterly report: Q3 2024


Recursion Pharmaceuticals Earnings release: Q3 2024

Nov 6, 2024, 2:30 AM EST - 1 year ago

Recursion Pharmaceuticals Earnings release: Q3 2024


Recursion Pharmaceuticals Slides: Q3 2024

Nov 6, 2024, 2:30 AM EST - 1 year ago

Recursion Pharmaceuticals Slides: Q3 2024


Recursion Pharmaceuticals Proxy statement: Proxy Filing

Oct 30, 2024, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Proxy statement: Proxy Filing


Recursion Pharmaceuticals Proxy statement: Proxy Filing

Oct 10, 2024, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Proxy statement: Proxy Filing


Recursion Pharmaceuticals Proxy statement: Proxy Filing

Sep 19, 2024, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Proxy statement: Proxy Filing


Recursion Pharmaceuticals Proxy statement: Proxy Filing

Sep 17, 2024, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Proxy statement: Proxy Filing


Recursion Pharmaceuticals Proxy statement: Proxy Filing

Sep 4, 2024, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Proxy statement: Proxy Filing


Recursion Pharmaceuticals Proxy statement: Proxy Filing

Sep 3, 2024, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Proxy statement: Proxy Filing


Recursion Pharmaceuticals Proxy statement: Proxy Filing

Aug 28, 2024, 8:00 AM EDT - 2 years ago

Recursion Pharmaceuticals Proxy statement: Proxy Filing


Recursion Pharmaceuticals Proxy statement: Proxy Filing

Aug 9, 2024, 8:00 AM EDT - 2 years ago

Recursion Pharmaceuticals Proxy statement: Proxy Filing


Floridaorange
Floridaorange Jul. 4 at 4:39 AM
$RXRX is the only publicly traded company that has assembled the combination of proprietary data generation, automated labs, AI research (Valence Labs), supercomputing (BioHive), foundation models, and an integrated discovery platform all under one roof. Buy, hold, wait, win.
0 · Reply
stockit111
stockit111 Jul. 4 at 1:27 AM
$RXRX What's next move, down to $3 again or hold $4 this time? Place your bets.
1 · Reply
AlgorithmApex
AlgorithmApex Jul. 3 at 9:38 PM
$RXRX starting to look like a real trend, not just a dead-cat bounce. Price action is holding up instead of fading, and that’s the key shift. If buyers keep defending dips, this can keep grinding higher.
0 · Reply
topstockalerts
topstockalerts Jul. 3 at 8:51 PM
$RXRX this is starting to look like a trend, not just a bounce
0 · Reply
NatesNotes
NatesNotes Jul. 3 at 5:15 PM
Now that my subscribers have had plenty of time to act on the information in both, I thought I'd share the last two issues of the newsletter on the free side of the website for those of you who may be interested! The link below will take you to the June issue (and the May issue will be just a click away once you get there), which includes some commentary on $SPCX and the frothiness of the market these days, and both issues include a fair amount of commentary discussing my thoughts on $MNKD as the story has been unfolding over the past couple of months (which, of course, is why I am sharing the link on the MNKD stream... though $AAPL, $NVDA, $RXRX and all the other recommended stocks are discussed as well). Anyhow, take a gander if you'd like... and please don't hesitate to ask if you have any questions after reading them! As always, kudos to everyone who has managed to keep their wits about them along the way - here's to more gains in the years ahead! Cheers! https://www.notwallstreet.com/the-frothiness-continues-to-grow-plus-spacex-mannkind-and-more-7-3-26/
4 · Reply
Sihtegroftnod
Sihtegroftnod Jul. 3 at 4:42 AM
$RXRX excited for 2026!!!
0 · Reply
ThisStockisDogShit
ThisStockisDogShit Jul. 3 at 2:13 AM
$FABC $JACK $RXRX $WEN Jack in the box fucking hates children clearly. Stay off our boards lil btch
2 · Reply
Reddskin
Reddskin Jul. 3 at 2:08 AM
1 · Reply
MorganHoratio
MorganHoratio Jul. 2 at 11:29 PM
One of the strongest sectors outside of AI right now is Biotech. Drug Discovery $TWST Twist Bioscience $ABSI Absci $RXRX Recursion $ABCL AbCellera $NRIX Nurix Therapeutics Smart money is pivoting to the ultimate AI crossover: Drug Discovery & TechBio! This sector captures AI’s efficiency boom without the tech sector’s valuation bubble. DNA giant TWST is absolutely ripping, up over 200% this year to fresh historical highs on strong revenue growth. Protein degradation leader NRIX also just smashed 52-week highs. Alongside Nvidia-backed RXRX, ABSI, and ABCL, this sector is using AI algorithms to shatter traditional pharma limits. Can AI Biotech outpace pure tech in H2? Which ticker is your top play: TWST, ABSI, RXRX, ABCL, or NRIX? Drop your picks below! 👇
0 · Reply
Esusthu
Esusthu Jul. 2 at 8:57 PM
$RXRX Very interesting biotech with major pharmaceutical partnerships and multiple near-term clinical catalysts that could drive significant long-term growth. I do believe!
0 · Reply
Spartangio
Spartangio Jul. 2 at 8:13 PM
$RXRX Not bad
0 · Reply
LoveRetailFroth
LoveRetailFroth Jul. 2 at 8:04 PM
$SANA Happy 4th guys🍺 $RXRX $TEM $ARBE
1 · Reply
UF7
UF7 Jul. 2 at 7:18 PM
0 · Reply
Vermilm
Vermilm Jul. 2 at 7:04 PM
$RXRX Cross fingers and toes, a close above 3.80 GOOD!
3 · Reply
ayedude
ayedude Jul. 2 at 7:03 PM
0 · Reply
topstockalerts
topstockalerts Jul. 2 at 6:01 PM
$RXRX waking up
0 · Reply
Zio_Fauss
Zio_Fauss Jul. 2 at 5:58 PM
$RXRX To all my fellow longs: something is definitely brewing. We’re seeing unusual activity, and real money is starting to flow in. This could finally be the move we’ve been waiting for. The shorts are getting increasingly nervous, and you can feel the pressure building. I believe the real squeeze may be just around the corner, and when it hits, it could be absolutely brutal for anyone still betting against this stock. Stay sharp. This could get interesting very quickly.
1 · Reply
StreakGeek
StreakGeek Jul. 2 at 5:28 PM
0 · Reply
nbis2025
nbis2025 Jul. 2 at 5:08 PM
0 · Reply
Spartangio
Spartangio Jul. 2 at 4:59 PM
$RXRX Now GSK, Anthropic, Amazon and leading AI-bio platforms are embracing Boltz. The ecosystem around RXRX/Valence keeps expanding. And we should not follow the market boom!?
0 · Reply
ajmrtxl
ajmrtxl Jul. 2 at 3:54 PM
$RXRX 's latest data on SqueezeFinder
1 · Reply
Spartangio
Spartangio Jul. 2 at 3:25 PM
$RXRX semi to bio
0 · Reply